iRemedy’s “Project Vaccinate” Program is Gaining Traction in 2021 with Over 130 Million Needles and Syringes Delivered

9 day ago
iRemedy Secures Factory Capacity for Needles and Syringes Required for Administration of One+ Billion COVID-19 Vaccinations
STUART, FL – November 18, 2020 – The iRemedy Healthcare Companies, Inc. (“iRemedy” or “the Company”), pioneer of the iRemedy™ medical supply marketplace, today announced that in anticipation of COVID-19 vaccines becoming available soon, the Company has procured factory capacity for production of over one billion, FDA-approved hypodermic needles and syringes that will be required for administration of vaccinations to the public on a global basis.
3 months ago